Literature DB >> 17662572

Terminal delirium: recommendations from bereaved families' experiences.

Tatsuya Morita1, Tatsuo Akechi, Masayuki Ikenaga, Shinichi Inoue, Hiroyuki Kohara, Tatsuhiro Matsubara, Naoki Matsuo, Miki Namba, Takuya Shinjo, Kazuhiko Tani, Yosuke Uchitomi.   

Abstract

Although delirium is a common complication in terminally ill cancer patients and can cause considerable distress for family members, little is known about effective care strategies for terminal delirium. The primary aims of this study were 1) to clarify the distress levels of bereaved families and their perceived necessity of care; and 2) to explore the association between these levels and family-reported professional care practice, family-reported patient behavior, and their interpretation of the causes of delirium. A multicenter questionnaire survey was conducted on 560 bereaved family members of cancer patients who developed delirium during their final two weeks in eight certified palliative care units across Japan. We obtained 402 effective responses (response rate, 72%) and, as 160 families denied delirium episodes, 242 responses were analyzed. The bereaved family members reported that they were very distressed (32%) and distressed (22%) about the experience of terminal delirium. On the other hand, 5.8% reported that considerable or much improvement was necessary, and 31% reported some improvement was necessary in the professional care they had received. More than half of the respondents had ambivalent wishes, guilt and self-blame, and worries about staying with the patient. One-fourth to one-third reported that they felt a burden concerning proxy judgments, burden to others, acceptance, and helplessness. High-level emotional distress and family-perceived necessity of improvement were associated with a younger family age; male gender; their experience of agitation and incoherent speech; their interpretation of the causes of delirium as pain/physical discomfort, medication effects, or mental weakness/death anxiety; and their perception that medical staff were not present with the family, not respecting the patient's subjective world, not explaining the expected course with daily changes, and not relieving family care burden. In terminal delirium, a considerable number of families experienced high levels of emotional distress and felt some need for improvement of the specialized palliative care service. Control of agitation symptoms with careful consideration of ambivalent family wishes, providing information about the pathology of delirium, being present with the family, respecting the patient's subjective world, explaining the expected course with daily changes, and relieving family care burden can be useful care strategies.

Entities:  

Mesh:

Year:  2007        PMID: 17662572     DOI: 10.1016/j.jpainsymman.2007.01.012

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  19 in total

1.  Neuroleptic strategies for terminal agitation in patients with cancer and delirium at an acute palliative care unit: a single-centre, double-blind, parallel-group, randomised trial.

Authors:  David Hui; Allison De La Rosa; Annie Wilson; Thuc Nguyen; Jimin Wu; Marvin Delgado-Guay; Ahsan Azhar; Joseph Arthur; Daniel Epner; Ali Haider; Maxine De La Cruz; Yvonne Heung; Kimberson Tanco; Shalini Dalal; Akhila Reddy; Janet Williams; Sapna Amin; Terri S Armstrong; William Breitbart; Eduardo Bruera
Journal:  Lancet Oncol       Date:  2020-05-29       Impact factor: 41.316

2.  Neurolytic celiac plexus block reduces occurrence and duration of terminal delirium in patients with pancreatic cancer.

Authors:  Young-Chang P Arai; Makoto Nishihara; Kunio Kobayashi; Tamotsu Kanazawa; Nobuhiko Hayashi; Yukio Tohyama; Kikuyo Nishida; Maki Arakawa; Chiharu Suzuki; Akiko Kinoshita; Miki Kondo; Satuki Matsubara; Nami Yokoe; Ruiko Hayashi; Aya Ohta; Jun Sato; Takahiro Ushida
Journal:  J Anesth       Date:  2012-09-19       Impact factor: 2.078

3.  Predictors of response to corticosteroids for dyspnea in advanced cancer patients: a preliminary multicenter prospective observational study.

Authors:  Masanori Mori; Akemi Naito Shirado; Tatsuya Morita; Kenichiro Okamoto; Yoshinobu Matsuda; Yoshihisa Matsumoto; Hirohide Yamada; Hiroki Sakurai; Etsuko Aruga; Keisuke Kaneishi; Hiroaki Watanabe; Takashi Yamaguchi; Takuya Odagiri; Shuji Hiramoto; Hiroyuki Kohara; Naoki Matsuo; Hideki Katayama; Tomohiro Nishi; Takashi Matsui; Satoru Iwase
Journal:  Support Care Cancer       Date:  2016-11-29       Impact factor: 3.603

Review 4.  Treating an established episode of delirium in palliative care: expert opinion and review of the current evidence base with recommendations for future development.

Authors:  Shirley H Bush; Salmaan Kanji; José L Pereira; Daniel H J Davis; David C Currow; David Meagher; Kiran Rabheru; David Wright; Eduardo Bruera; Michael Hartwick; Pierre R Gagnon; Bruno Gagnon; William Breitbart; Laura Regnier; Peter G Lawlor
Journal:  J Pain Symptom Manage       Date:  2014-01-28       Impact factor: 3.612

5.  Current Pharmacotherapy Does Not Improve Severity of Hypoactive Delirium in Patients with Advanced Cancer: Pharmacological Audit Study of Safety and Efficacy in Real World (Phase-R).

Authors:  Toru Okuyama; Kazuhiro Yoshiuchi; Asao Ogawa; Satoru Iwase; Naosuke Yokomichi; Akihiro Sakashita; Keita Tagami; Keiichi Uemura; Rika Nakahara; Tatsuo Akechi
Journal:  Oncologist       Date:  2019-01-04

6.  Ease of screening for depression and delirium in patients enrolled in inpatient hospice care.

Authors:  Sanjai Rao; Frank D Ferris; Scott A Irwin
Journal:  J Palliat Med       Date:  2011-01-19       Impact factor: 2.947

Review 7.  Family and healthcare staff's perception of delirium.

Authors:  Enrico Mossello; Flaminia Lucchini; Francesca Tesi; Laura Rasero
Journal:  Eur Geriatr Med       Date:  2020-01-01       Impact factor: 1.710

Review 8.  Clarifying delirium management: practical, evidenced-based, expert recommendations for clinical practice.

Authors:  Scott A Irwin; Rosene D Pirrello; Jeremy M Hirst; Gary T Buckholz; Frank D Ferris
Journal:  J Palliat Med       Date:  2013-03-12       Impact factor: 2.947

Review 9.  Delirium in patients with cancer: assessment, impact, mechanisms and management.

Authors:  Peter G Lawlor; Shirley H Bush
Journal:  Nat Rev Clin Oncol       Date:  2014-09-02       Impact factor: 66.675

10.  Developing guidelines on the assessment and treatment of delirium in older adults at the end of life.

Authors:  Susan Brajtman; David Wright; David B Hogan; Pierre Allard; Venera Bruto; Deborah Burne; Laura Gage; Pierre R Gagnon; Cheryl A Sadowski; Sherri Helsdingen; Kimberley Wilson
Journal:  Can Geriatr J       Date:  2011-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.